Bausch Health Companies Inc. (BHC) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 6:45 PM EST
Company Participants
Thomas Appio – CEO & Director
Jonathan Sadeh – Executive VP, Chief Medical Officer and Head of R&D
Jean-Jacques Charhon – Executive VP & CFO
Presentation
Unknown Analyst
Hi all, and welcome to the session. My name is Arvind, and I’m an associate with JPMorgan, and I’m excited today to welcome Bausch Health. With us today we have Thomas Appio, CEO; JJ Charhon, CFO; and Jonathan Sadeh, CMO. As a reminder on format, this will be a 20-minute presentation followed by 20 minutes of Q&A. So please hold any questions until the end. Thank you.
Thomas Appio
CEO & Director
Thank you, and welcome this afternoon to the session to talk about Bausch Health. So since becoming the CEO, I saw an opportunity to redefine Bausch Health’s future. So with the focus of the first thing I wanted to focus on was profitable growth both on the top line and the bottom line. The second thing was to improve the capital structure. So reduce debt and look at our maturity profile and give us some runway. Of course, as you all know, we refinanced $9.5 billion of debt in 2025. And lastly was to invest in our people, in our products and our processes. And as I take you through this presentation, you’ll see what we’ve been able to accomplish in terms of building a team in terms of beginning to develop our portfolio of products for the future and clearly, our processes.
But before I begin, I’d like to note that today’s presentation includes forward-looking statements, which are subject to risks and uncertainties. Actual results may differ materially. Please refer to our SEC filings for additional information.
With that, let me get
